Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Begg C. B., Engstrom P. F. Eligibility and extrapolation in cancer clinical trials. J Clin Oncol. 1987 Jun;5(6):962–968. doi: 10.1200/JCO.1987.5.6.962. [DOI] [PubMed] [Google Scholar]
- Bobbio M., Demichelis B., Giustetto G. Completeness of reporting trial results: effect on physicians' willingness to prescribe. Lancet. 1994 May 14;343(8907):1209–1211. doi: 10.1016/s0140-6736(94)92407-4. [DOI] [PubMed] [Google Scholar]
- DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177–188. doi: 10.1016/0197-2456(86)90046-2. [DOI] [PubMed] [Google Scholar]
- Dickersin K., Scherer R., Lefebvre C. Identifying relevant studies for systematic reviews. BMJ. 1994 Nov 12;309(6964):1286–1291. doi: 10.1136/bmj.309.6964.1286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gray R., James R., Mossman J., Stenning S. AXIS--a suitable case for treatment. UK Coordinating Committee on Cancer Research (UKCCCR) Colorectal Cancer Subcommittee. Br J Cancer. 1991 Jun;63(6):841–845. doi: 10.1038/bjc.1991.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gregory W. M., Richards M. A., Malpas J. S. Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials. J Clin Oncol. 1992 Feb;10(2):334–342. doi: 10.1200/JCO.1992.10.2.334. [DOI] [PubMed] [Google Scholar]
- Gøtzsche P. C. Reference bias in reports of drug trials. Br Med J (Clin Res Ed) 1987 Sep 12;295(6599):654–656. [PMC free article] [PubMed] [Google Scholar]
- Himel H. N., Liberati A., Gelber R. D., Chalmers T. C. Adjuvant chemotherapy for breast cancer. A pooled estimate based on published randomized control trials. JAMA. 1986 Sep 5;256(9):1148–1159. doi: 10.1001/jama.256.9.1148. [DOI] [PubMed] [Google Scholar]
- King J. F., Grant A., Keirse M. J., Chalmers I. Beta-mimetics in preterm labour: an overview of the randomized controlled trials. Br J Obstet Gynaecol. 1988 Mar;95(3):211–222. doi: 10.1111/j.1471-0528.1988.tb06860.x. [DOI] [PubMed] [Google Scholar]
- Peto R. Why do we need systematic overviews of randomized trials? Stat Med. 1987 Apr-May;6(3):233–244. doi: 10.1002/sim.4780060306. [DOI] [PubMed] [Google Scholar]
- Pignon J. P., Arriagada R., Ihde D. C., Johnson D. H., Perry M. C., Souhami R. L., Brodin O., Joss R. A., Kies M. S., Lebeau B. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992 Dec 3;327(23):1618–1624. doi: 10.1056/NEJM199212033272302. [DOI] [PubMed] [Google Scholar]
- Simon R., Altman D. G. Statistical aspects of prognostic factor studies in oncology. Br J Cancer. 1994 Jun;69(6):979–985. doi: 10.1038/bjc.1994.192. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Simon R. The role of overviews in cancer therapeutics. Stat Med. 1987 Apr-May;6(3):389–396. doi: 10.1002/sim.4780060335. [DOI] [PubMed] [Google Scholar]
- Slevin M. L., Stubbs L., Plant H. J., Wilson P., Gregory W. M., Armes P. J., Downer S. M. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ. 1990 Jun 2;300(6737):1458–1460. doi: 10.1136/bmj.300.6737.1458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stewart L. A., Clarke M. J. Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. Stat Med. 1995 Oct 15;14(19):2057–2079. doi: 10.1002/sim.4780141902. [DOI] [PubMed] [Google Scholar]
- Stewart L. A., Parmar M. K. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet. 1993 Feb 13;341(8842):418–422. doi: 10.1016/0140-6736(93)93004-k. [DOI] [PubMed] [Google Scholar]
- Thompson S. G. Why sources of heterogeneity in meta-analysis should be investigated. BMJ. 1994 Nov 19;309(6965):1351–1355. doi: 10.1136/bmj.309.6965.1351. [DOI] [PMC free article] [PubMed] [Google Scholar]
